Fjarde Ap Fonden Johnson & Johnson Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Johnson & Johnson stock. As of the latest transaction made, Fjarde Ap Fonden holds 768,313 shares of JNJ stock, worth $112 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

768,313

Previous 718,313 6.96%

Holding current value

$112 Million

Previous $114 Million 9.58%

% of portfolio

1.27%

Previous 1.26%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$145.48 - $167.38 $7.27 Million - $8.37 Million	50,000 Added 6.96%	768,313 $125 Million
Q1 2024 Apr 25, 2024	BUY	$155.22 - $162.74 $2.18 Million - $2.28 Million	14,034 Added 1.99%	718,313 $114 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $4.98 Million - $5.44 Million	-34,229 Reduced 4.63%	704,279 $110 Million
Q3 2023 Oct 23, 2023	SELL	$155.75 - $174.48 $12.6 Million - $14.2 Million	-81,163 Reduced 9.9%	738,508 $115 Million
Q2 2023 Aug 02, 2023	BUY	$154.35 - $166.11 $5.26 Million - $5.66 Million	34,100 Added 4.34%	819,671 $136 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $2.08 Million - $2.49 Million	-13,800 Reduced 1.73%	785,571 $122 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $9.87 Million - $11.1 Million	-61,631 Reduced 7.16%	799,371 $141 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $32.6 Million - $36 Million	193,800 Added 29.05%	861,002 $153 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $42,697 - $48,489	-270 Reduced 0.04%	667,202 $118 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $7.36 Million - $8.17 Million	-47,200 Reduced 6.6%	667,472 $114 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $2.89 Million - $3.21 Million	-17,899 Reduced 2.44%	714,672 $115 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $5.85 Million - $6.28 Million	-36,700 Reduced 4.77%	732,571 $121 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $964,341 - $1.07 Million	6,300 Added 0.83%	769,271 $126 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $3.72 Million - $4.26 Million	-27,100 Reduced 3.43%	762,971 $120 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $4.07 Million - $4.46 Million	29,000 Added 3.81%	790,071 $118 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $4.38 Million - $5.29 Million	34,042 Added 4.68%	761,071 $107 Million
Q1 2020 May 11, 2020	SELL	$111.14 - $153.99 $4.69 Million - $6.5 Million	-42,207 Reduced 5.49%	727,029 $95.3 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $1.67 Million - $1.92 Million	-13,100 Reduced 1.67%	769,236 $112 Million
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $622,055 - $696,485	-4,900 Reduced 0.62%	782,336 $101 Million
Q2 2019 Jul 17, 2019	SELL	$131.15 - $144.24 $5.86 Million - $6.45 Million	-44,700 Reduced 5.37%	787,236 $110 Million
Q1 2019 Apr 29, 2019	BUY	$125.72 - $139.79 $21.5 Million - $23.9 Million	171,008 Added 25.87%	831,936 $116 Million
Q4 2018 Jan 31, 2019	SELL	$122.84 - $147.84 $6.36 Million - $7.66 Million	-51,800 Reduced 7.27%	660,928 $85.3 Million
Q3 2018 Nov 09, 2018	SELL	$121.58 - $142.88 $3.61 Million - $4.25 Million	-29,712 Reduced 4.0%	712,728 $98.5 Million
Q2 2018 Jul 12, 2018	SELL	$119.4 - $131.76 $2.21 Million - $2.44 Million	-18,521 Reduced 2.43%	742,440 $90.1 Million
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $892,963 - $1.06 Million	7,138 Added 0.95%	760,961 $97.5 Million
Q4 2017 Feb 12, 2018	BUY	$131.22 - $143.62 $14.8 Million - $16.2 Million	113,115 Added 17.65%	753,823 $105 Million
Q3 2017 Nov 07, 2017	BUY	$129.47 - $135.38 $1.76 Million - $1.84 Million	13,582 Added 2.17%	640,708 $83.3 Million
Q2 2017 Aug 08, 2017	BUY	N/A	627,126	627,126 $83 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account